To investigate the correlation between DSCAM-AS1 and clinicopathological features of patients with CRC, the 56 patients were split into two groups based on the median value: DSCAM-AS1 high group and DSCAM-AS1-low group. This evidence concerns the gene DSCAM and colorectal carcinoma.